UnitedHealth Group (NYSE:UNH) Given New $680.00 Price Target at UBS Group

UnitedHealth Group (NYSE:UNH) had its price objective increased by UBS Group from $640.00 to $680.00 in a research report sent to investors on Thursday, Benzinga reports. UBS Group currently has a buy rating on the healthcare conglomerate’s stock.

Other equities analysts have also recently issued research reports about the stock. Deutsche Bank Aktiengesellschaft boosted their price target on shares of UnitedHealth Group from $545.00 to $562.00 and gave the stock a buy rating in a research note on Friday, April 19th. Argus increased their target price on UnitedHealth Group from $570.00 to $600.00 and gave the company a buy rating in a research note on Wednesday, July 17th. StockNews.com upgraded UnitedHealth Group from a hold rating to a buy rating in a report on Wednesday, July 10th. Baird R W raised UnitedHealth Group to a strong-buy rating in a report on Thursday, May 30th. Finally, Piper Sandler increased their price target on shares of UnitedHealth Group from $566.00 to $571.00 and gave the company an overweight rating in a research report on Wednesday, April 17th. One investment analyst has rated the stock with a hold rating, nineteen have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of Buy and a consensus target price of $614.17.

UnitedHealth Group Price Performance

UNH stock opened at $565.33 on Thursday. The firm has a 50 day moving average of $504.56 and a 200-day moving average of $500.44. The company has a current ratio of 0.88, a quick ratio of 0.85 and a debt-to-equity ratio of 0.67. The firm has a market capitalization of $520.32 billion, a P/E ratio of 34.56, a price-to-earnings-growth ratio of 1.66 and a beta of 0.60. UnitedHealth Group has a 12 month low of $436.38 and a 12 month high of $581.50.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, topping the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm had revenue of $98.86 billion for the quarter, compared to analysts’ expectations of $98.73 billion. During the same quarter in the prior year, the firm posted $6.14 earnings per share. The business’s quarterly revenue was up 6.4% on a year-over-year basis. As a group, sell-side analysts predict that UnitedHealth Group will post 27.68 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Stockholders of record on Monday, June 17th were given a $2.10 dividend. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.88. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.49%. The ex-dividend date was Monday, June 17th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 51.34%.

Insider Buying and Selling

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares in the company, valued at approximately $4,507,748.55. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the sale, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by insiders.

Hedge Funds Weigh In On UnitedHealth Group

Several large investors have recently made changes to their positions in the business. BKM Wealth Management LLC purchased a new stake in UnitedHealth Group during the 4th quarter valued at about $2,016,000. Galvin Gaustad & Stein LLC increased its position in shares of UnitedHealth Group by 1.0% during the fourth quarter. Galvin Gaustad & Stein LLC now owns 63,016 shares of the healthcare conglomerate’s stock valued at $33,176,000 after acquiring an additional 596 shares in the last quarter. Orgel Wealth Management LLC lifted its position in UnitedHealth Group by 19.0% in the 4th quarter. Orgel Wealth Management LLC now owns 583 shares of the healthcare conglomerate’s stock valued at $307,000 after acquiring an additional 93 shares in the last quarter. RiverPark Advisors LLC increased its holdings in shares of UnitedHealth Group by 2.5% in the 4th quarter. RiverPark Advisors LLC now owns 5,881 shares of the healthcare conglomerate’s stock worth $3,096,000 after purchasing an additional 142 shares in the last quarter. Finally, Investment Advisory Services Inc. TX ADV lifted its holdings in shares of UnitedHealth Group by 1.0% during the fourth quarter. Investment Advisory Services Inc. TX ADV now owns 3,288 shares of the healthcare conglomerate’s stock valued at $1,731,000 after purchasing an additional 32 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.